FIELD: medicine.
SUBSTANCE: in patients one should detect initial CD-25 value followed by Zenapax injection. After its first injection one should sample peripheral blood at an interval of 1-3 d to measure absolute CD-25 value. At its increased value being above initial level by more than 25-30% for a certain patient therapy should be classified as insufficient and then it is necessary to intensify the mode of Zenapax injection.
EFFECT: higher efficiency.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC METHOD FOR RENAL ALLOGRAFT REJECTION | 2007 |
|
RU2348932C1 |
| METHOD FOR PREDICTION OF RISK OF COMPLICATIONS OF CADAVERIC LIVER TRANSPLANTATION IN RECIPIENTS | 2010 |
|
RU2424529C1 |
| METHOD OF PROPHYLAXIS OF REJECTION OF TRANSPLANTED ORGAN | 0 |
|
SU1424854A1 |
| METHOD OF DIAGNOSING KIDNEY ALLOTRANSPLANT REJECTION | 2009 |
|
RU2430370C2 |
| METHOD FOR REPAIRING REPERFUSION INJURY OF ALLOKIDNEY | 2002 |
|
RU2213583C1 |
| METHOD OF DETERMINING THE REJECTION OF KIDNEY TRANSPLANT | 0 |
|
SU1175488A1 |
| MIC THERAPY FOR SPECIFIC IMMUNOSUPRESSION DURING TRANSPLANTATION | 2019 |
|
RU2806545C2 |
| METHOD OF TREATING SECONDARY IMMUNE DEFICIENCY IN SEPSIS AND SEPTIC SHOCK IN UROLOGY | 2014 |
|
RU2586243C1 |
| METHOD FOR EARLY DIAGNOSIS OF TRANSPLANT REJECTION | 2019 |
|
RU2728683C1 |
| METHOD OF THERAPEUTIC ABORTION IN RENAL ALLOGRAFT RECIPIENT | 2010 |
|
RU2438682C2 |
